Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer

NCT00007631 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1131

Enrollment

FED

Sponsor class

Conditions

Carcinoma, Basal Cell
Carcinoma, Squamous Cell
Skin Neoplasms

Interventions

DRUG: Tretinoin 0.1% cream or placebo
OTHER: Placebo

Sponsor

US Department of Veterans Affairs

Collaborators

[object Object]